ATC kodları
- L03AA16 emegfilgrastim
- L03AA17 pegteograstim
- L03AB interferonlar
- L03AB01 interferon alfa doğal
- L03AB02 interferon beta doğal
- L03AB03 interferon gama
- L03AB04 interferon alfa-2a
- L03AB05 interferon alfa-2b
- L03AB06 interferon alfa-n1
- L03AB07 interferon beta-1a
- L03AB08 interferon beta-1b
- L03AB09 interferon alfacon-1
- L03AB10 peginterferon alfa-2b
- L03AB11 peginterferon alfa-2a
- L03AB12 albinterferon alfa-2b
- L03AB13 peginterferon beta-1a
- L03AB14 cepeginterferon alfa-2b
- L03AB15 ipginterferon alfa-2b
- L03AB60 peginterferon alfa-2b, kombinasyonlar
- L03AB61 peginterferon alfa-2a, kombinasyonlar
- L03AC interlökinler
- L03AC01 aldeslökin
- L03AC02 oprelvekin
- L03AX ATC'deki diğer immünostimülanlar
- L03AX01 mercimek
- L03AX02 roquinimex
- L03AX03 BCG aşısı
- L03AX04 pegademaz
- L03AX05 pidotimod
- L03AX07 poli ben:C
- L03AX08 poli ICLC
- L03AX09 timopentin
- L03AX10 immünosiyanin
- L03AX11 taşermin
- L03AX12 melanom aşısı
- L03AX13 glatiramer asetat
- L03AX14 histamin dihidroklorür
- L03AX15 mifamurtid
- L03AX16 plerixafor
- L03AX17 sipuleucel-T
- L03AX18 kridanimod
- L03AX19 dasiprotimut-T
- L03AX21 elapegademaz
- L04 İMMUNOSUpresanlar
- L04A İMMUNOSUpresanlar
- L04AA seçici immünosupresanlar
- L04AA02 muromonab-CD3
- L04AA03 antilenfosit immünoglobulin (at)
- L04AA04 antitimosit immünoglobulin (tavşan)
- L04AA06 mikofenolik asit
- L04AA10 sirolimus
- L04AA13 leflunomid
- L04AA15 alefacept
- L04AA18 everolimus
- L04AA19 gusperimus
- L04AA21 efalizumab
- L04AA22 şeker hastalığı
- L04AA23 natalizumab
- L04AA24 abatacept
- L04AA25 ekulizumab
- L04AA26 belimumab
- L04AA27 fingolimod
- L04AA28 belatasept
- L04AA29 tofacitinib
- L04AA31 teriflunomid
- L04AA32 apremilast
- L04AA33 vedolizumab
- L04AA34 alemtuzumab
- L04AA35 begelomab
- L04AA36 okrelizumab
- L04AA37 barisitinib
- L04AA38 ozanimod
- L04AA39 empalumab
- L04AA40 kladribin
- L04AA41 imlifidaz
- L04AA42 siponimod
- L04AA43 ravulizumab
- L04AA44 upadacitinib
- L04AA45 filgotinib
- L04AA46 itasitinib
- L04AA47 inebilizumab
- L04AB Tümör nekroz faktörü alfa (TNF-alfa) inhibitörleri
- L04AB01 etanersept
- L04AB02 infliximab
- L04AB03 afelimomab
- L04AB04 adalimumab
- L04AB05 sertolizumab pegol
- L04AB06 golimumab
- L04AB07 görüş açısı
- L04AC interlökin inhibitörleri
- L04AC01 daklizumab
- L04AC02 basiliximab
- L04AC03 anakinra
- L04AC04 rilonacept
- L04AC05 ustekinumab
- L04AC07 tocilizumab
- L04AC08 canakinumab
- L04AC09 briakinumab
- L04AC10 secukinumab
- L04AC11 siltuximab